Literature DB >> 16669472

Epidemiological analysis of tongue cancer in South Australia for the 24-year period, 1977-2001.

L Lam1, R M Logan, C Luke.   

Abstract

BACKGROUND: Tongue cancer (141 ICD-9) is the most common intra-oral malignancy in Western countries. In recent decades, reported tongue cancer incidence and mortality rates have increased both in Europe and in the United States, whilst survival has not improved. This study aimed to determine the epidemiology and survival trends of tongue cancer in South Australia over the 24-year period from 1977 to 2001.
METHODS: Population-based data for tongue cancer were provided by the Central Cancer Registry Unit of the Epidemiology Branch of the South Australian Department of Health. Age-standardized incidence and mortality rates for males and females were calculated. Kaplan-Meier survival analysis was conducted according to time periods, age, sex and tongue sub-sites. Cox regression analysis was used to determine factors that influenced survival.
RESULTS: During this 24-year period, 611 cases of tongue cancer (398 males, 213 females) were reported, the majority of which were squamous cell carcinomas. The most common age of diagnosis was 65-69 years in males and 60-64 years in females. Fifty cases (8.18 per cent of all tongue cancer cases) occurred in patients 40 years or younger. The most common cancer sub-sites reported were 'unspecified site' (48.45 per cent), lateral border (25.53 per cent) and base (18.49 per cent) of the tongue. The age-standardized incidence and mortality rates for males and females in South Australia were relatively low and stable, and there was no significant improvement in survival of tongue cancer over this period. Significant predictors for survival were sex, age and tongue sub-sites, with male, advanced age and base of tongue associated with poorer survival.
CONCLUSIONS: Tongue cancer is an important health issue associated with poor survival. Early detection and diagnosis is important in order to improve survival rate for this malignancy.

Entities:  

Mesh:

Year:  2006        PMID: 16669472     DOI: 10.1111/j.1834-7819.2006.tb00395.x

Source DB:  PubMed          Journal:  Aust Dent J        ISSN: 0045-0421            Impact factor:   2.291


  8 in total

1.  EGFRwt/vIII-PKM2-β-catenin cascade affects proliferation and chemo-sensitivity in head and neck squamous cell carcinoma.

Authors:  Chao Jing; Xin Qu; Zhaoqing Li; Chuanqiang Wu; Minghui Zhao; Yu Wang; Shanshan Sun; Shengchi Zhang; Jinliang Chen; Yu Qiao; Xiaomeng Hu; Xiaofeng Yao; Rui Jin; Xudong Wang; Lun Zhang; Xuan Zhou
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  Oral tongue cancer patients show a better overall survival than base of tongue cancer patients.

Authors:  Liuyang Zhang; Xuan Zhou; Xiaofeng Yao; Yansheng Wu; Qiang Zhang; Lun Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-03       Impact factor: 4.553

3.  Suppression of the Growth and Invasion of Human Head and Neck Squamous Cell Carcinomas via Regulating STAT3 Signaling and the miR-21/β-catenin Axis with HJC0152.

Authors:  Yu Wang; Sinan Wang; Yansheng Wu; Yu Ren; Zhaoqing Li; Xiaofeng Yao; Chao Zhang; Na Ye; Chao Jing; Jiabin Dong; Kailiang Zhang; Shanshan Sun; Minghui Zhao; Wenyu Guo; Xin Qu; Yu Qiao; Haiying Chen; Lingping Kong; Rui Jin; Xudong Wang; Lun Zhang; Jia Zhou; Qiang Shen; Xuan Zhou
Journal:  Mol Cancer Ther       Date:  2017-01-30       Impact factor: 6.261

4.  Trends of lip, oral cavity and oropharyngeal cancers in Australia 1982-2008: overall good news but with rising rates in the oropharynx.

Authors:  Anura Ariyawardana; Newell W Johnson
Journal:  BMC Cancer       Date:  2013-07-06       Impact factor: 4.430

5.  WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.

Authors:  Xuan Zhou; Yu Ren; Aiqin Liu; Rui Jin; Qingping Jiang; Yuanyuan Huang; Lingping Kong; Xudong Wang; Lun Zhang
Journal:  Sci Rep       Date:  2014-12-17       Impact factor: 4.379

6.  Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion.

Authors:  Yu Wang; Wenyu Guo; Zhaoqing Li; Yansheng Wu; Chao Jing; Yu Ren; Minghui Zhao; Lingping Kong; Chao Zhang; Jiabin Dong; Yu Shuang; Shanshan Sun; Jinliang Chen; Chuanqiang Wu; Yu Qiao; Xin Qu; Xudong Wang; Lun Zhang; Rui Jin; Xuan Zhou
Journal:  Int J Oncol       Date:  2018-02-28       Impact factor: 5.650

7.  IFNα2b augments immune responses of cisplatin+5-fluorouracil treated tongue squamous cell carcinoma patients--a preliminary study.

Authors:  Kalyan Kusum Mukherjee; Anamika Bose; Diptendu Ghosh; Koustav Sarkar; Shyamal Goswami; Smarajit Pal; Jaydip Biswas; Rathindranath Baral
Journal:  Indian J Med Res       Date:  2012-07       Impact factor: 2.375

8.  Cyclin D1 and Ki-67 expression correlates to tumor staging in tongue squamous cell carcinoma.

Authors:  Eduardo-Pereira Guimarães; Marina-Lara de Carli; Felipe-Fornias Sperandio; João-Adolfo-Costa Hanemann; Alessandro-Antônio-Costa Pereira
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.